Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "GCP Risk Management and Risk-Based Monitoring" training has been added to ResearchAndMarkets.com's offering. Good Clinical Practice (GCP) is a set of ...
Hello.This is Falmer.In our previous article, 'Can AI Be Used for Clinical Trial Subject Recruitment?', we organized the ...
Pfizer and Bristol-Myers Squibb (BMS) recently raised questions with and sought further clarity from the US Food and Drug Administration (FDA) on a draft guidance related to the risk-based monitoring ...
In this free webinar, gain insight into the key elements to reduce risk for clinical trials. Attendees will learn how Independent Review and Data Analytics in eCOA strengthen endpoint integrity and ...
The American Gastroenterology Association (AGA) Institute issued new clinical practice guidelines, providing evidence-based recommendations for managing hepatitis B reactivation (HBVr) in at-risk ...
The U.S. Food and Drug Administration (FDA) recently finalized its guidance, “A Risk-Based Approach to Monitoring of Clinical Investigations” (the “2023 RBM Guidance”) which follows up on the Agency’s ...
The US Food and Drug Administration (FDA) on Tuesday issued final guidance meant to assist drug and medical device makers in developing risk-based monitoring strategies for clinical investigations ...
Clinical trials can often take between six and seven years to complete, but that timeline isn’t always practical for the problems pharmaceutical companies are trying to solve. Additionally, six years ...
Risk monitoring is the ongoing process of identifying, understanding, assessing, monitoring, managing, and mitigating risks that could adversely affect an organization's operations, value, assets and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results